{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:44:18Z","timestamp":1793994258106,"version":"4.8.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"American Heart Association (AHA) Transformational Project Award","award":["961032"],"award-info":[{"award-number":["961032"]}],"id":[{"id":"https:\/\/ror.org\/013kjyp64","id-type":"ROR","asserted-by":"crossref"}]},{"name":"American Cancer Society (ACS) Research Scholar Grants","award":["RSG-24-1316992-01-ET"],"award-info":[{"award-number":["RSG-24-1316992-01-ET"]}],"id":[{"id":"https:\/\/ror.org\/02e463172","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82522061"],"award-info":[{"award-number":["82522061"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Pujiang Program","award":["23PJ1407600"],"award-info":[{"award-number":["23PJ1407600"]}]},{"name":"Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support","award":["20240705"],"award-info":[{"award-number":["20240705"]}],"id":[{"id":"https:\/\/ror.org\/05tewj457","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"DOI":"10.1007\/s10456-026-10031-1","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:37:34Z","timestamp":1770896254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Vascular normalization by erianin unleashes CAR-T immunotherapy in glioblastoma"],"prefix":"10.1007","volume":"29","author":[{"given":"Shiling","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanni","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changrui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"10031_CR1","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","volume":"371","author":"SL Maude","year":"2014","unstructured":"Maude SL, Frey N, Shaw PA, Aplenc R, Barrett DM, Bunin NJ, Chew A, Gonzalez VE, Zheng Z, Lacey SF, Mahnke YD, Melenhorst JJ, Rheingold SR, Shen A, Teachey DT, Levine BL, June CH, Porter DL, Grupp SA (2014) Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med 371:1507\u20131517","journal-title":"N Engl J Med"},{"key":"10031_CR2","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41587-024-02446-2","volume":"43","author":"U Uslu","year":"2025","unstructured":"Uslu U, June CH (2025) Beyond the blood: expanding CAR T cell therapy to solid tumors. Nat Biotechnol 43:506\u2013515","journal-title":"Nat Biotechnol"},{"key":"10031_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41571-023-00832-4","volume":"21","author":"SM Albelda","year":"2024","unstructured":"Albelda SM (2024) CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn. Nat Rev Clin Oncol 21:47\u201366","journal-title":"Nat Rev Clin Oncol"},{"key":"10031_CR4","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1158\/2159-8290.CD-13-0985","volume":"4","author":"I Melero","year":"2014","unstructured":"Melero I, Rouzaut A, Motz GT, Coukos G (2014) T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapy. Cancer Discov 4:522\u2013526","journal-title":"Cancer Discov"},{"key":"10031_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s43018-020-00147-8","volume":"2","author":"W Ma","year":"2021","unstructured":"Ma W, Wang Y, Zhang R, Yang F, Zhang D, Huang M, Zhang L, Dorsey JF, Binder ZA, O\u2019Rourke DM, Fraietta JA, Gong Y, Fan Y (2021) Targeting PAK4 to reprogram the vascular microenvironment and improve CAR-T immunotherapy for glioblastoma. Nat Cancer 2:83\u201397","journal-title":"Nat Cancer"},{"key":"10031_CR6","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/nm.2537","volume":"17","author":"SM Weis","year":"2011","unstructured":"Weis SM, Cheresh DA (2011) Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med 17:1359\u20131370","journal-title":"Nat Med"},{"key":"10031_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nrd3455","volume":"10","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet P, Jain RK (2011) Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 10:417\u2013427","journal-title":"Nat Rev Drug Discov"},{"key":"10031_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nri.2017.145","volume":"18","author":"Y Huang","year":"2018","unstructured":"Huang Y, Kim BYS, Chan CK, Hahn SM, Weissman IL, Jiang W (2018) Improving immune-vascular crosstalk for cancer immunotherapy. Nat Rev Immunol 18:195\u2013203","journal-title":"Nat Rev Immunol"},{"key":"10031_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41568-019-0224-7","volume":"20","author":"JH Sampson","year":"2020","unstructured":"Sampson JH, Gunn MD, Fecci PE, Ashley DM (2020) Brain immunology and immunotherapy in brain tumours. Nat Rev Cancer 20:12\u201325","journal-title":"Nat Rev Cancer"},{"key":"10031_CR10","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1172\/JCI84876","volume":"126","author":"M Huang","year":"2016","unstructured":"Huang M, Liu T, Ma P, Mitteer RA Jr., Zhang Z, Kim HJ, Yeo E, Zhang D, Cai P, Li C, Zhang L, Zhao B, Roccograndi L, O\u2019Rourke DM, Dahmane N, Gong Y, Koumenis C, Fan Y (2016) c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma. J Clin Invest 126:1801\u20131814","journal-title":"J Clin Invest"},{"key":"10031_CR11","doi-asserted-by":"publisher","first-page":"10123","DOI":"10.1158\/0008-5472.CAN-07-3127","volume":"67","author":"EM Zeisberg","year":"2007","unstructured":"Zeisberg EM, Potenta S, Xie L, Zeisberg M, Kalluri R (2007) Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 67:10123\u201310128","journal-title":"Cancer Res"},{"key":"10031_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj4678","volume":"10","author":"F Yang","year":"2024","unstructured":"Yang F, Akhtar MN, Zhang D, El-Mayta R, Shin J, Dorsey JF, Zhang L, Xu X, Guo W, Bagley SJ, Fuchs SY, Koumenis C, Lathia JD, Mitchell MJ, Gong Y, Fan Y (2024) An immunosuppressive vascular niche drives macrophage polarization and immunotherapy resistance in glioblastoma. Sci Adv 10:eadj4678","journal-title":"Sci Adv"},{"key":"10031_CR13","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.trecan.2019.05.007","volume":"5","author":"Y Fan","year":"2019","unstructured":"Fan Y (2019) Vascular detransformation for cancer therapy. Trends Cancer 5:460\u2013463","journal-title":"Trends Cancer"},{"key":"10031_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.devcel.2009.01.004","volume":"16","author":"E Dejana","year":"2009","unstructured":"Dejana E, Tournier-Lasserve E, Weinstein BM (2009) The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 16:209\u2013221","journal-title":"Dev Cell"},{"key":"10031_CR15","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrm1911","volume":"7","author":"AK Olsson","year":"2006","unstructured":"Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L (2006) VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol 7:359\u2013371","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10031_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq3558","volume":"15","author":"F Yang","year":"2023","unstructured":"Yang F, Zhang D, Jiang H, Ye J, Zhang L, Bagley SJ, Winkler J, Gong Y, Fan Y (2023) Small-molecule toosendanin reverses macrophage-mediated immunosuppression to overcome glioblastoma resistance to immunotherapy. Sci Transl Med 15:eabq3558","journal-title":"Sci Transl Med"},{"key":"10031_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10456-024-09913-z","volume":"27","author":"F Yang","year":"2024","unstructured":"Yang F, Lee G, Fan Y (2024) Navigating tumor angiogenesis: therapeutic perspectives and myeloid cell regulation mechanism. Angiogenesis 27:333\u2013349","journal-title":"Angiogenesis"},{"key":"10031_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104239","volume":"83","author":"A Xiong","year":"2022","unstructured":"Xiong A, Zhang J, Chen Y, Zhang Y, Yang F (2022) Integrated single-cell transcriptomic analyses reveal that GPNMB-high macrophages promote PN-MES transition and impede T cell activation in GBM. EBioMedicine 83:104239","journal-title":"EBioMedicine"},{"key":"10031_CR19","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1038\/s41467-018-06893-9","volume":"9","author":"G Xiong","year":"2018","unstructured":"Xiong G, Stewart RL, Chen J, Gao T, Scott TL, Samayoa LM, O\u2019Connor K, Lane AN, Xu R (2018) Collagen prolyl 4-hydroxylase 1 is essential for HIF-1\u03b1 stabilization and TNBC chemoresistance. Nat Commun 9:4456","journal-title":"Nat Commun"},{"key":"10031_CR20","doi-asserted-by":"publisher","first-page":"6403","DOI":"10.1073\/pnas.88.15.6403","volume":"88","author":"NK Damle","year":"1991","unstructured":"Damle NK, Aruffo A (1991) Vascular cell adhesion molecule 1 induces T-cell antigen receptor-dependent activation of CD4+T lymphocytes. Proc Natl Acad Sci U S A 88:6403\u20136407","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10031_CR21","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrc2442","volume":"8","author":"G Bergers","year":"2008","unstructured":"Bergers G, Hanahan D (2008) Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 8:592\u2013603","journal-title":"Nat Rev Cancer"},{"key":"10031_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ccr.2006.11.021","volume":"11","author":"TT Batchelor","year":"2007","unstructured":"Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen PJ, Zhu M, Ancukiewicz M, Mrugala MM, Plotkin S, Drappatz J, Louis DN, Ivy P, Scadden DT, Benner T, Loeffler JS, Wen PY, Jain RK (2007) AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 11:83\u201395","journal-title":"Cancer Cell"},{"key":"10031_CR23","doi-asserted-by":"publisher","first-page":"17561","DOI":"10.1073\/pnas.1215397109","volume":"109","author":"Y Huang","year":"2012","unstructured":"Huang Y, Yuan J, Righi E, Kamoun WS, Ancukiewicz M, Nezivar J, Santosuosso M, Martin JD, Martin MR, Vianello F, Leblanc P, Munn LL, Huang P, Duda DG, Fukumura D, Jain RK, Poznansky MC (2012) Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy. Proc Natl Acad Sci U S A 109:17561\u201317566","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10031_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/srep34306","volume":"6","author":"Z Yu","year":"2016","unstructured":"Yu Z, Zhang T, Gong C, Sheng Y, Lu B, Zhou L, Ji L, Wang Z (2016) Erianin inhibits high glucose-induced retinal angiogenesis via blocking ERK1\/2-regulated HIF-1\u03b1-VEGF\/VEGFR2 signaling pathway. Sci Rep 6:34306","journal-title":"Sci Rep"},{"key":"10031_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0149-3","volume":"5","author":"P Chen","year":"2020","unstructured":"Chen P, Wu Q, Feng J, Yan L, Sun Y, Liu S, Xiang Y, Zhang M, Pan T, Chen X, Duan T, Zhai L, Zhai B, Wang W, Zhang R, Chen B, Han X, Li Y, Chen L, Liu Y, Huang X, Jin T, Zhang W, Luo H, Chen X, Li Y, Li Q, Li G, Zhang Q, Zhuo L, Yang Z, Tang H, Xie T, Ouyang X, Sui X (2020) Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium\/calmodulin-dependent ferroptosis. Signal Transduct Target Ther 5:51","journal-title":"Signal Transduct Target Ther"},{"key":"10031_CR26","first-page":"223","volume":"18","author":"Y Gong","year":"2004","unstructured":"Gong Y, Fan Y, Liu L, Wu D, Chang Z, Wang Z (2004) Erianin induces a JNK\/SAPK-dependent metabolic inhibition in human umbilical vein endothelial cells. In Vivo 18:223\u2013228","journal-title":"In Vivo"},{"key":"10031_CR27","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.ejca.2004.01.041","volume":"40","author":"YQ Gong","year":"2004","unstructured":"Gong YQ, Fan Y, Wu DZ, Yang H, Hu ZB, Wang ZT (2004) In vivo and in vitro evaluation of erianin, a novel anti-angiogenic agent. Eur J Cancer 40:1554\u20131565","journal-title":"Eur J Cancer"},{"key":"10031_CR28","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.bbrc.2019.06.096","volume":"516","author":"XP Cao","year":"2019","unstructured":"Cao XP, Cao Y, Li WJ, Zhang HH, Zhu ZM (2019) P4HA1\/HIF1\u03b1 feedback loop drives the glycolytic and malignant phenotypes of pancreatic cancer. Biochem Biophys Res Commun 516:606\u2013612","journal-title":"Biochem Biophys Res Commun"},{"key":"10031_CR29","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.12406","volume":"21","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Yin Y, Zhao H, Shi Y, Zhang W, Yang Z, Liu T, Huang Y, Yu Z (2021) P4HA1 regulates human colorectal cancer cells through HIF1\u03b1-mediated Wnt signaling. Oncol Lett 21:145","journal-title":"Oncol Lett"},{"key":"10031_CR30","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1093\/neuonc\/noae040","volume":"26","author":"S Yang","year":"2024","unstructured":"Yang S, Zhan Q, Su D, Cui X, Zhao J, Wang Q, Hong B, Ju J, Cheng C, Yang E, Kang C (2024) HIF1\u03b1\/ATF3 partake in PGK1 K191\/K192 succinylation by modulating P4HA1\/succinate signaling in glioblastoma. Neuro Oncol 26:1405\u20131420","journal-title":"Neuro Oncol"},{"key":"10031_CR31","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.1074\/jbc.273.11.5989","volume":"273","author":"P Annunen","year":"1998","unstructured":"Annunen P, Autio-Harmainen H, Kivirikko KI (1998) The novel type II prolyl 4-hydroxylase is the main enzyme form in chondrocytes and capillary endothelial cells, whereas the type I enzyme predominates in most cells. J Biol Chem 273:5989\u20135992","journal-title":"J Biol Chem"},{"key":"10031_CR32","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721\u2013732","journal-title":"Nat Rev Cancer"},{"key":"10031_CR33","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm0603-677","volume":"9","author":"CW Pugh","year":"2003","unstructured":"Pugh CW, Ratcliffe PJ (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9:677\u2013684","journal-title":"Nat Med"},{"key":"10031_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1471-2407-13-108","volume":"13","author":"L Zhang","year":"2013","unstructured":"Zhang L, Huang G, Li X, Zhang Y, Jiang Y, Shen J, Liu J, Wang Q, Zhu J, Feng X, Dong J, Qian C (2013) Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1\u03b1 in hepatocellular carcinoma. BMC Cancer 13:108","journal-title":"BMC Cancer"},{"key":"10031_CR35","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/jcp.22264","volume":"225","author":"G Storci","year":"2010","unstructured":"Storci G, Sansone P, Mari S, D\u2019Uva G, Tavolari S, Guarnieri T, Taffurelli M, Ceccarelli C, Santini D, Chieco P, Marcu KB, Bonaf\u00e8 M (2010) TNFalpha up-regulates SLUG via the NF-kappaB\/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype. J Cell Physiol 225:682\u2013691","journal-title":"J Cell Physiol"},{"key":"10031_CR36","doi-asserted-by":"publisher","first-page":"16653","DOI":"10.1074\/jbc.M115.636944","volume":"290","author":"X Xu","year":"2015","unstructured":"Xu X, Tan X, Tampe B, Sanchez E, Zeisberg M, Zeisberg EM (2015) Snail is a direct target of Hypoxia-inducible Factor 1\u03b1 (HIF1\u03b1) in hypoxia-induced endothelial to mesenchymal transition of human coronary endothelial cells. J Biol Chem 290:16653\u201316664","journal-title":"J Biol Chem"},{"key":"10031_CR37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/35000034","volume":"2","author":"E Batlle","year":"2000","unstructured":"Batlle E, Sancho E, Franc\u00ed C, Dom\u00ednguez D, Monfar M, Baulida J, Garc\u00eda De Herreros A (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2:84\u201389","journal-title":"Nat Cell Biol"},{"key":"10031_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg4485","volume":"8","author":"VP Ma","year":"2022","unstructured":"Ma VP, Hu Y, Kellner AV, Brockman JM, Velusamy A, Blanchard AT, Evavold BD, Alon R, Salaita K (2022) The magnitude of LFA-1\/ICAM-1 forces fine-tune TCR-triggered T cell activation. Sci Adv 8:eabg4485","journal-title":"Sci Adv"},{"key":"10031_CR39","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10456-022-09863-4","volume":"26","author":"P Nowak-Sliwinska","year":"2023","unstructured":"Nowak-Sliwinska P, van Beijnum JR, Griffioen CJ, Huinen ZR, Sopesens NG, Schulz R, Jenkins SV, Dings RPM, Groenendijk FH, Huijbers EJM, Thijssen V, Jonasch E, Vyth-Dreese FA, Jordanova ES, Bex A, Bernards R, de Gruijl TD, Griffioen AW (2023) Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy. Angiogenesis 26:279\u2013293","journal-title":"Angiogenesis"},{"key":"10031_CR40","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1182\/blood.V88.2.667.bloodjournal882667","volume":"88","author":"AW Griffioen","year":"1996","unstructured":"Griffioen AW, Damen CA, Blijham GH, Groenewegen G (1996) Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. Blood 88:667\u2013673","journal-title":"Blood"},{"key":"10031_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ccell.2024.12.001","volume":"43","author":"S Ma","year":"2025","unstructured":"Ma S, Ong LT, Jiang Z, Lee WC, Lee PL, Yusuf M, Ditzel HJ, Wang Y, Chen Q, Wang W, Wu X, Tan EY, Yu Q (2025) Targeting P4HA1 promotes CD8(+) T cell progenitor expansion toward immune memory and systemic anti-tumor immunity. Cancer Cell 43:213-231.e219","journal-title":"Cancer Cell"},{"key":"10031_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01329-3","volume":"8","author":"P Wang","year":"2023","unstructured":"Wang P, Jia X, Lu B, Huang H, Liu J, Liu X, Wu Q, Hu Y, Li P, Wei H, Liu T, Zhao D, Zhang L, Tian X, Jiang Y, Qiao Y, Nie W, Ma X, Bai R, Peng C, Dong Z, Liu K (2023) Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1\/2. Signal Transduct Target Ther 8:96","journal-title":"Signal Transduct Target Ther"},{"key":"10031_CR43","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1021\/acs.jmedchem.1c01605","volume":"65","author":"Y Sheng","year":"2022","unstructured":"Sheng Y, Chen Y, Zeng Z, Wu W, Wang J, Ma Y, Lin Y, Zhang J, Huang Y, Li W, Zhu Q, Wei X, Li S, Wisanwattana W, Li F, Liu W, Suksamrarn A, Zhang G, Jiao W, Wang F (2022) Identification of pyruvate carboxylase as the cellular target of natural bibenzyls with potent anticancer activity against hepatocellular carcinoma via metabolic reprogramming. J Med Chem 65:460\u2013484","journal-title":"J Med Chem"},{"key":"10031_CR44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy R, Pollard JW (2014) Tumor-associated macrophages: from mechanisms to therapy. Immunity 41:49\u201361","journal-title":"Immunity"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-026-10031-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10456-026-10031-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-026-10031-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:04:15Z","timestamp":1770901455000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10456-026-10031-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["10031"],"URL":"https:\/\/doi.org\/10.1007\/s10456-026-10031-1","relation":{},"ISSN":["1573-7209"],"issn-type":[{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"18"}}